Aptus Pharma IPO Details
| IPO Open Date | September 23, 2025 |
| IPO Close Date | September 25, 2025 |
| Face Value | ₹10 Per Equity Share |
| IPO Price Band | ₹65 to ₹70 Per Share |
| Issue Size | Approx ₹13.02 Crores |
| Fresh Issue | Approx ₹13.02 Crores |
| Issue Type | Book Built Issue |
| IPO Listing | BSE SME |
| DRHP Draft Prospectus |  |
| RHP Draft Prospectus | |
Aptus Pharma IPO Review & Key Points
- Review:
Aptus Pharma IPO Market Lot
The Aptus Pharma IPO minimum market lot is 4,000 shares with ₹2,80,000 application amount.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 2 | 4,000 | ₹2,80,000 |
| Retail Maximum | 2 | 4,000 | ₹2,80,000 |
| S-HNI Minimum | 3 | 6,000 | ₹4,20,000 |
| S-HNI Maximum | 7 | 14,000 | ₹9,80,000 |
| B-HNI Minimum | 8 | 16,000 | ₹11,20,000 |
IPO Reservation
| Investor Category | Share Offered | % Shares |
| Market Maker Shares Offered | 94,000 Shares | 5.05% |
| QIB Shares Offered | 8,80,000 Shares | 47.31% |
| Anchor Investor | 5,28,000 Shares | 28.39% |
| QIB (Ex. Anchor) | 3,52,000 Shares | 18.92% |
| NII Shares Offered | 2,66,000 Shares | 14.30% |
| bNII > ₹10L | – Shares | -% |
| sNII < ₹10L | – Shares | -% |
| Retail Shares Offered | 6,20,000 Shares | 33.33% |
Aptus Pharma IPO Anchor Investors
| Anchor Bidding Date | September 22, 2025 |
| Anchor Investors List | |
| Shares Offered | 5,28,000 Shares |
| Anchor Size | 3.70 Cr. |
| lock-in period end date 50% shares (30 Days) | October 26, 2025 |
| lock-in period end date 50% shares (90 Days) | December 25, 2025 |
Aptus Pharma IPO Dates
The Aptus Pharma IPO date is September 23 and the close date is September 25. The Aptus Pharma IPO allotment will be finalized on September 26 and the IPO listing on September 30.
| IPO Open Date: | September 23, 2025 |
| IPO Close Date: | September 25, 2025 |
| Basis of Allotment: | September 26, 2025 |
| Refunds: | September 29, 2025 |
| Credit to Demat Account: | September 29, 2025 |
| IPO Listing Date: | September 30, 2025 |
| IPO Bidding Cut-off Time: | September 25, 2025 – 5 PM |
Promoters and Holding Pattern
The promoters of the company are Tejash Maheshchandra Hathi, Chatrabhuj Vallabhbhai Butani, Kapilbhai Hasmukhbhai Chandarana, Ghanshyam Vinubhai Pansuriya, Milly Chetan Lalseta, Riddhish Natwarlal Tanna, Gaurang Rameshchandra Thakker, Kripaliben Mayank Thakker And Kunjal Piyushbhai Unadkat.
| Particular | Shares | % Share |
| Promoter Holding Pre Issue | 50,00,000 | 100% |
| Promoter Holding Post Issue | 68,60,000 | 72.89% |
Objects of the Issue & Utilisation of proceeds
| Purpose | Crores | % |
| Capital Expenditure for Office Premises with furniture and Industrial Racks | 1.63 | -% |
| Working Capital | 8.00 | -% |
| General Corporate Purpose | – | -% |
About Aptus Pharma IPO
Aptus Pharma is one of the leading companies in terms of marketing and selling pharmaceutical products. This firm does not have its own factories but gets the products made through contract manufacturers.
The company provides a diverse range of pharmaceutical products catering to various therapeutic categories, including anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, anti-diabetic, lipid-lowering, and general wellness products. The company works with many healthcare professionals in different areas, including general doctors, child specialists, women’s health doctors, heart specialists, diabetes doctors, brain specialists, and others.
The company has various promoters, wherein Mr. Tejash Maheshchandra Hathi has more than 20 years of experience in the pharmaceutical industry.
Aptus Pharma IPO Company Financial Report
The company reported revenue of ₹24.64 crores in 2025 against ₹17.88 crores in 2024. The company reported profit of ₹3.10 crores in 2025 against profit of ₹0.80 crores in 2024.
Amount ₹ in Crores
| Period Ended | Revenue | Expense | PAT | Assets |
| 2023 | ₹13.90 | ₹13.60 | ₹0.19 | ₹6.22 |
| 2024 | ₹17.88 | ₹16.76 | ₹0.80 | ₹10.03 |
| 2025 | ₹24.64 | ₹20.44 | ₹3.10 | ₹21.92 |
Aptus Pharma IPO Valuation – FY2025
Check Aptus Pharma IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| KPI | Values |
| ROE: | 44.50% |
| ROCE: | 45.66% |
| EBITDA Margin: | 19.31% |
| PAT Margin: | -% |
| Debt to equity ratio: | 1.49 |
| Earning Per Share (EPS): | ₹6.37 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 44.50% |
| Net Asset Value (NAV): | ₹13.93 |
Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Zota health care limited | 3.16 | 382.12 | 2.72 | 110.83 | 261.90 Cr. |
| Sunrest Lifescience Limited | 4.66 | 10.56 | 12.36 | 37.72 | 33.12 Cr. |
| Lincoln Pharmaceuticals Limited | 41.11 | 13.53 | 12.26 | 335.34 | 645.71 Cr. |
IPO Lead Managers aka Merchant Bankers
- Interactive Financial Services Ltd.
Company Address
Aptus Pharma Ltd.
Ashutosh Buildcon, Opp. Slok – 2,
Nr. Harikrupa Logistic Park,
Aslali, Ahmedabad, Daskroi,
Ahmedabad, Gujarat, 382427
Phone: +91 76004 27827
Email: [email protected]
Website: https://aptus-pharma.com/
IPO Registrar
Bigshare Services Pvt.Ltd.
Phone: +91-22-6263 8200
Email: [email protected]
Website: https://ipo.bigshareonline.com/IPO_Status.html
Aptus Pharma IPO FAQs
What is Aptus Pharma IPO?
When Aptus Pharma IPO will open for subscription?
What is Aptus Pharma IPO Investors Portion?
How to Apply the Aptus Pharma IPO?
What is Aptus Pharma IPO Issue Size?
What is Aptus Pharma IPO Price Band?
What is Aptus Pharma IPO Lot Size?
What is the Aptus Pharma IPO Allotment Date?
What is the Aptus Pharma IPO Listing Date?
Note: The Aptus Pharma IPO price band and date are officially announced. The (Aptus Pharma IPO grey market premium) will be added to the IPO GMP page as it will start).
